Short Interest in Cosmos Health Inc. (NASDAQ:COSM) Increases By 40.6%

Cosmos Health Inc. (NASDAQ:COSM) was the recipient of a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 804,000 shares, an increase of 40.6% from the February 13th total of 571,900 shares. Based on an average trading volume of 412,700 shares, the days-to-cover ratio is presently 1.9 days. Currently, 4.9% of the company’s shares are sold short.

Insider Activity

In other news, CFO Georgios Terzis purchased 85,778 shares of the stock in a transaction dated Friday, December 20th. The shares were purchased at an average price of $0.58 per share, with a total value of $49,751.24. Following the transaction, the chief financial officer now owns 727,263 shares in the company, valued at $421,812.54. The trade was a 13.37 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Grigorios Siokas purchased 257,334 shares of the stock in a transaction dated Friday, December 20th. The shares were purchased at an average cost of $0.58 per share, for a total transaction of $149,253.72. Following the transaction, the chief executive officer now owns 3,774,314 shares in the company, valued at approximately $2,189,102.12. The trade was a 7.32 % increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders have bought 1,175,618 shares of company stock valued at $701,169. 15.61% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Cosmos Health stock. Geode Capital Management LLC boosted its stake in Cosmos Health Inc. (NASDAQ:COSM) by 29.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 193,432 shares of the company’s stock after buying an additional 43,704 shares during the period. Geode Capital Management LLC owned approximately 0.83% of Cosmos Health worth $129,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 12.61% of the company’s stock.

Cosmos Health Trading Down 1.0 %

Shares of COSM stock traded down $0.00 on Friday, hitting $0.48. 63,232 shares of the stock traded hands, compared to its average volume of 507,766. The firm’s 50-day moving average price is $0.65 and its two-hundred day moving average price is $0.76. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.24 and a current ratio of 1.44. The stock has a market capitalization of $11.26 million, a PE ratio of -0.20 and a beta of 5.60. Cosmos Health has a twelve month low of $0.44 and a twelve month high of $1.58.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.